Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Oct;6(4):339–343. doi: 10.1111/j.1365-2125.1978.tb00861.x

Digoxin compliance in patients from general practice.

G D Johnston, D G McDevitt
PMCID: PMC1429482  PMID: 698030

Abstract

1. Compliance with digoxin therapy has been assessed in a group of fifty patients receiving the drug in general practice but not attending hospital. 2. Compliance was estimated by comparing plasma digoxin concentrations before and after a 10 day period of measured digoxin consumption and by tablet counting. 3. Twelve patients had plasma concentrations which increased by more than 0.4 ng/ml during monitored intake and eight other patients took less than 80% of their tablets. These twenty patients were considered non-compliant. 4. A further three patients in whom plasma digoxin levels were zero when first seen but increased substantially during the run-in period were also adjudged non-compliant. 5. Non-compliance with prescribed digoxin dosage occurred, therefore, in 46% of the patients studied.

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carruthers S. G., Kelly J. G., McDevitt D. G. Plasma digoxin concentrations in patients on admission to hospital. Br Heart J. 1974 Jul;36(7):707–712. doi: 10.1136/hrt.36.7.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Johnston G. D., McDevitt D. G. Variations of plasma digoxin concentrations in the equilibrium state after multiple dosing. Br J Clin Pharmacol. 1978 Jan;5(1):92–93. doi: 10.1111/j.1365-2125.1978.tb01606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Lindenbaum J., Mellow M. H., Blackstone M. O., Butler V. P., Jr Variation in biologic availability of digoxin from four preparations. N Engl J Med. 1971 Dec 9;285(24):1344–1347. doi: 10.1056/NEJM197112092852403. [DOI] [PubMed] [Google Scholar]
  4. Manninen V., Apajalahti A., Melin J., Karesoja M. Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet. 1973 Feb 24;1(7800):398–400. doi: 10.1016/s0140-6736(73)90252-3. [DOI] [PubMed] [Google Scholar]
  5. Ojala K., Karjalainen J., Reissell P. Radioimmunoassay of digoxin. Lancet. 1972 Jan 15;1(7742):150–150. doi: 10.1016/s0140-6736(72)90718-0. [DOI] [PubMed] [Google Scholar]
  6. Shaw T. R., Howard M. R., Hamer J. Variation in the biological availability of digoxin. Lancet. 1972 Aug 12;2(7772):303–307. doi: 10.1016/s0140-6736(72)92908-x. [DOI] [PubMed] [Google Scholar]
  7. Steiness E. Renal tubular secretion of digoxin. Circulation. 1974 Jul;50(1):103–107. doi: 10.1161/01.cir.50.1.103. [DOI] [PubMed] [Google Scholar]
  8. Whiting B., Sumner D. J., Goldberg A. An assessment of digoxin radio-immunoassay. Scott Med J. 1973 May;18(3):69–74. doi: 10.1177/003693307301800301. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES